<DOC>
	<DOC>NCT02799654</DOC>
	<brief_summary>In this Post Market Clinical Follow-up Study (PMCF Study), the short-term clinical and radiological results of the cementless Excia T® prosthesis in routine clinical use shall be assessed and the migration taking place in the first 24 months evaluated.</brief_summary>
	<brief_title>Excia T Cementless EBRA Study</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Written patient consent to study participation Age &gt; 18 years Indication for primary THA with cementless Excia T® stem Pregnancy THA after fracture Rheumatoid arthritis Systemic disorders, treated with Cortisone or other pharmaceuticals, potentially compromising the bone quality Patient physically or mentally not able to follow the postoperative examination routine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Total Hip Arthroplasty</keyword>
</DOC>